We could not find any results for:
Make sure your spelling is correct or try broadening your search.
TC BioPharm (Holdings) PLC is a clinical-stage biopharmaceutical company focused on developing novel immunotherapy products that are based on its proprietary allogeneic gamma delta T (abbreviated as GD-T) cell platform. TC BioPharm (Holdings) PLC is a clinical-stage biopharmaceutical company focused on developing novel immunotherapy products that are based on its proprietary allogeneic gamma delta T (abbreviated as GD-T) cell platform.
TCBP Provides Quarterly Update on the ACHIEVE (UK) Clinical Trial PR Newswire EDINBURGH, Scotland, Dec. 4, 2024 Positive safety data, allowing for exploration of higher TCB008 doses4 UK-based...
TCBP Awarded Non-Dilutive Funding, ScaleReady's G-Rex® Grant PR Newswire EDINBURGH, Scotland, Nov. 12, 2024 EDINBURGH, Scotland, Nov. 12, 2024 /PRNewswire/ -- TC BioPharm (Holdings) PLC ("TC...
TCBP Provides Shareholder Update and Highlights Recent Milestone Achievements PR Newswire EDINBURGH, Scotland, Oct. 30, 2024 EDINBURGH, Scotland, Oct. 30, 2024 /PRNewswire/ -- TC BioPharm...
TCBP Responds to False Social Media Claim PR Newswire EDINBURGH, Scotland, Oct. 25, 2024 TC BioPharm remains compliant with all Nasdaq listing requirements and will continue trading on the...
A Scotland-based biotech company is finding a tremendous amount of success so far during Tuesday’s session after the company announced it entered into a research planning To read the full...
TCBP Enters Research Planning Collaboration with Dr. Carlos Maluquer de Motes for Mpox Therapeutic PR Newswire EDINBURGH, Scotland, Oct. 22, 2024 EDINBURGH, Scotland, Oct. 22, 2024 /PRNewswire/...
TCBP Announces Artificial Intelligence Initiative with Partner Carnegie Mellon University for Donor Screening PR Newswire EDINBURGH, Scotland, Oct. 3, 2024 TC BioPharm Limited is partnering with...
TCBP Announces Site Opening of Guys and St. Thomas Hospital PR Newswire EDINBURGH, Scotland, Sept. 25, 2024 Additional London-based clinic to increase enrolment velocityLeading hospital with...
TCBP to Present at the 2024 ThinkEquity Conference in NYC PR Newswire EDINBURGH, Scotland, Sept. 24, 2024 EDINBURGH, Scotland, Sept. 24, 2024 /PRNewswire/ -- TC BioPharm (Holdings) PLC ("TC...
/C O R R E C T I O N -- TC BioPharm/ PR Newswire EDINBURGH, Scotland, Sept. 12, 2024 In the news release, TCBP Announces First Patient Completed the Full Fose Regimen in ACHIEVE Clinical Trial...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DR |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DR |
12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DR |
26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DR |
52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DR |
156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DR |
260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DR |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions